In de Pijplijn
Vanaf 30 juni 2010 Bristol-Myers Squibb’s pipeline is één van de meest innovatieve in de industrie.
Exploratory Development compounds are investigational drugs that are post discovery through Phase II. Full Development compounds are investigational drugs that are in late-stage clinical development, or have been submitted to regulatory agencies for approval. Marketed Product Development compounds have been approved in at least one major market and are among approved medicines that are driving current and future growth while continuing their clinical development to determine whether additional indications and formulations will benefit patients. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
